Basic information
- CAS
4611-02-3- Standard SMILES
CCN(CC)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl- InChIKey
XXQMDKCWUYZXOF-UHFFFAOYSA-N- Molecular formula
- C19H24Cl2N2S
- Average molar mass
- 383.4 g/mol
- Monoisotopic mass
- 382.1037253
Names & identifiers
- Preferred name
- 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-diethyl-, hydrochloride (1:1)
- IUPAC
- 3-(2-chlorophenothiazin-10-yl)-N,N-diethylpropan-1-amine;hydrochloride
- English name
- Chlorproethazine
- Molecular formula
- C19H24Cl2N2S
- Molecular weight
- 0
Names & synonyms
Chlorproethazine hydrochloride4611-02-3Chlorproethazine HCl4909 RPNSC-169470520P4U8V2Z4909-RPDTXSID10196726RefChem:907948chlorproethazine monohydrochlorideDTXCID5011921710H-Phenothiazine-10-propanamine, 2-chloro-N,N-diethyl-, hydrochloride (1:1)
Show more names
225-018-8Neuriplege3-(2-chlorophenothiazin-10-yl)-N,N-diethylpropan-1-amine;hydrochlorideNeuriplege (TN)EINECS 225-018-8NSC 169470R.P. 4909R.p. 4909 hydrochloride
Database identifiers
- CAS
4611-02-3- PubChem CID
- 71829
- DTXSID
DTXSID10196726- ChEMBL
CHEMBL2105938- UNII
- 520P4U8V2Z
- EC Number
- 225-018-8
Properties
Computed structural properties
- Topological polar surface area
- 31.8 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 3
- Rotatable bonds
- 6
- Heavy atoms
- 24
- Formal charge
- 0
- Complexity
- 363
Physicochemical properties
- Melting point
- 180 · 180-182°C
- Boiling point
- 1 · Free base bp1 225-240°
- storage temp.
- -20 °C · -20°C Freezer
- solubility
- Chloroform (Slightly), Methanol (Slightly)
- form
- Solid
- color
- White to Off-White
- FDA UNII
- 520 P4U8V2Z · 520P4U8V2Z
- Toxicity
- 50 oral · LD50 oral in mouse: 300mg/kg
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Safety data
- Toxicity
- LD50 oral in mouse: 300mg/kg
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)
Applications
UsesTopical analgesic.
Suppliers6 total
安耐吉化学&3A（安徽泽升科技有限公司）021-58432009 400-005-6266 · [email protected]
凯试（上海）科技有限公司021-50135380 · [email protected]
艾吉析科技（上海）有限公司17717235263 17717235263 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…